The diagnosis of neuroendocrine tumours (NETs) and monitoring of therapy in many
patients relies mainly on morphological imaging techniques such as computed tomography …

Neuroendocrine tumours (NET) diagnosis has represented a major challenge in the past
decades. The introduction of somatostatin receptor scintigraphy in the diagnostic work-up …

Nuclear medicine plays an important role in the imaging of neuroendocrine tumors (NETs).
Somatostatin receptor scintigraphy (SRS) with 111In-labeled somatostatin receptor analogs …

Somatostatin receptor (SSTR) PET has demonstrated a significant improvement over
conventional imaging (CI) in patients with neuroendocrine tumors (NETs). SSTR PET should …

Abstract Purpose Neuroendocrine tumours (NETs) can be imaged with scintigraphy using
radiolabelled somatostatin analogues. The aim of our study was to compare the value of 68 …

Somatostatin receptor imaging is a valuable tool in the diagnosis, follow-up, and treatment
planning of neuroendocrine tumor (NET). PET-based tracers using 68Ga as the radioisotope …

Neuroendocrine tumours (NETs) are rare, heterogeneous, and often hormonally active
neoplasms. Nuclear medicine (NM) imaging using single photon-and positron-emitting …

In patients with neuroendocrine tumours (NETs), a combination of morphological imaging
and nuclear medicine techniques is mandatory for primary tumour visualization, staging and …

We evaluated the clinical value of positron emission tomography (PET) using 18 F-
fluorodeoxyglucose (FDG) for neuroendocrine tumor (NET) detection. Sixteen patients with …

Different tracers have been proposed in nuclear medicine to visualize neuroendocrine
tumours; the majority are based on specific uptake mechanisms while some are aspecific …